Related Experiment Video
Updated: Aug 5, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Rheumatic fever recurrence: a possible cause of restenosis after percutaneous mitral valvuloplasty
A Nigri1, N Alessandri, E Martuscelli
1Institute of Cardiac Surgery, La Sapienza University of Rome, Italy. antonio.nigri@uniroma1.it
Background:
We evaluated the occurrence of a rapid process of restenosis after percutaneous mitral valvuloplasty (PMV), initiated by the recurrence of acute rheumatic fever. Restenosis after PMV has been mainly related to a high echocardiographic score (> or = 8) indicating a severely compromised mitral valve apparatus.
Methods:
From 1986 to 1996, 120 patients underwent PMV by the transseptal approach at our Institution. The mean follow-up time was 58 +/- 32 months (range 3 months to 9 years).
Results:
Restenosis occurred in 10 patients (8.3%): in 4 restenosis was found within a relatively short period of time (1 to 3 months) following a documented recurrence of acute rheumatic fever; in the other 6 patients there was a gradual loss of the initial gain in the mitral valve area.
Conclusions:
These data suggest two potential mechanisms of restenosis: 1) a more common slow process, due to turbulent flow-trauma on the mitral valve; 2) a rapid process that relates to valvulitis consequent to a recurrence of acute rheumatic fever. In consideration of the second possibility, after PMV prophylactic treatment may be warranted at least in those patients who are at high risk of streptococcal infection.
Insights
A rapid restenosis process after percutaneous mitral valvuloplasty (PMV) can occur due to recurrent acute rheumatic fever. Prophylactic treatment may be considered for high-risk patients to prevent this complication.
Area of Science:
- Cardiology
- Valvular Heart Disease
- Rheumatic Heart Disease
Background:
- Percutaneous mitral valvuloplasty (PMV) is a procedure to treat mitral stenosis.
- Restenosis, the re-narrowing of the mitral valve, is a known complication after PMV.
- Acute rheumatic fever recurrence can trigger rapid restenosis.
Purpose of the Study:
- To evaluate the occurrence of rapid restenosis after PMV.
- To investigate the role of recurrent acute rheumatic fever in PMV restenosis.
- To identify potential mechanisms and preventive strategies for restenosis after PMV.
Main Methods:
- A retrospective study of 120 patients who underwent transseptal PMV from 1986 to 1996.
- Mean follow-up duration of 58 months.
- Analysis of restenosis occurrence and its timing relative to acute rheumatic fever recurrence.
Main Results:
- Restenosis occurred in 8.3% of patients (10 out of 120).
- Four patients experienced rapid restenosis within 1-3 months post-PMV, associated with rheumatic fever recurrence.
- Six patients showed a gradual loss of mitral valve area gain over time.
Conclusions:
- Two mechanisms of restenosis after PMV are suggested: a slow process from turbulent flow-trauma and a rapid process linked to rheumatic fever recurrence.
- Prophylactic treatment might be beneficial for high-risk patients susceptible to streptococcal infections to prevent rapid restenosis.
- Further research into prophylactic strategies is warranted, especially for patients with a history of rheumatic fever.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease III: Medical Management

